Swiss drugmaker Roche said it has agreed to buy LumiraDx’s Point of Care diagnostics platform business for about $295 million. Shares of LumiraDx rose about 20%, to 76 cents in aftermarket trading. The transaction...
AstraZeneca to buy China’s Gracell Biotechnologies in $1.2 billion deal
AstraZeneca said it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo-Swedish pharma company furthers its cell therapy ambitions and boosts its presence in China, the world’s second-largest...
Biocon weighs sale of $1.5 billion generic API business
Biocon is evaluating a plan to sell its generic active pharmaceutical ingredient (API) business – estimated to be worth $1.5 billion – to reduce its overall debt, though it is yet to take any concrete...
Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share
Sun Pharmaceutical Industries said it has revised upwards the price at which it proposed to fully acquire Israel-based Taro Pharmaceutical Industries to USD 43 per share in cash. In May this year, the company announced...
AbbVie to buy drug developer Cerevel for $8.7 billion
AbbVie said it would buy Cerevel Therapeutics, a developer of drugs for neurological conditions, for about $8.7 billion in a bid to replace revenue as its arthritis drug Humira faces a raft of new competition. It marks...
MedAlliance acquired by Cordis for $1.13 billion
Swiss-based medical technology company MedAlliance has announced acquisition by Cordis for $1.13 billion. Cordis will play a pivotal role in the marketing, distribution, and global accessibility of MedAlliance’s...
AstraZeneca Pharma India plans to sell Bengaluru plant
AstraZeneca Pharma India plans to sell its production facility in Bengaluru as part of a strategic review of the global manufacturing and supply network by its parent, according to a regulatory filing. The company...
Eris Lifesciences acquires Biocon Biologics’ nephro, derma units for Rs 366 crore
Eris Lifesciences said it has entered into a definitive agreement to acquire Biocon Biologics’ dermatology and nephrology branded formulations business units in India for Rs 366 crore. Eris said the acquisition...
Mankind Pharma and Baidyanath Ayurveda in race for government’s IMPCL
Mankind Pharma and Baidyanath Ayurveda are among the companies that have submitted expressions of interest (EoIs) to acquire 100% of government-owned Ayurveda company Indian Medicines Pharmaceutical Corporation (IMPCL)...
Zydus Lifesciences acquires UK-based LiqMeds Group for Rs 690 crore
Zydus Lifesciences said it has acquired UK-based LiqMeds Group which specialises in oral liquid products for GBP 68 million (Rs 690 crores) in an all cash deal. Zydus will pay an upfront consideration of GBP 68 million...
Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy
U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval for its proposed $43 billion acquisition of cancer drug maker Seagen. Pfizer announced the deal in March, its largest purchase in a string of...
Cipla stake sale plan faces hurdle as promoters differ on valuation: Report
The likely Cipla stake sale plan has come across a tricky hurdle as reportedly the promoters are not aligned in view regarding the common valuation. Differences among founders may lead to delay in deal until common...
